前列腺癌血清PSA\PSAD与Gleason评分\临床分期的相关性研究(2)
 |
| 第1页 |
参见附件。
PSAD已被证实在血清总PSA 4—10 ng/ml时对于前列腺癌的早期发现具有重要的临床意义,但其在预测前列腺癌的Gleason评分和临床分期方面的研究尚存在争议。
本组数据显示前列腺癌PSA值与Gleason评分、临床分期呈正相关性。PSAD值与Gleason评分及前列腺癌临床分期无相关。上述结果与许多学者的研究结果大同小异,期待其他更多的研究来探讨PSA在预测前列腺癌预后方面的意义。
参考文献
1.Wang MC,Valenzuela LA,Murphy GP,Chu TM.Purification of a human prostate specific antigen. Invest Urol 1979,17(2):159-163.
2.StameyTA,Yan gN,Hay AR,et,a1.Prostate—specific antigen as a serum marker for adenocarcinoma of the prostate.N Engl JMed 1987;317(15):909—916
3.StameyTA,KabalinJN,McNealJE,et,a1.Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate.II.Radical prostatectomy treated patients.JUrol 1989;141(5):1076—1083
4.Oesterling JE,Chan DW,Epstein JI,et,a1.Prostate specificantigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radicalprostatectomy.J Urol 1988;139(4):766—772
5.Partin AW,CarterliB,Chan DW eta1.Prostate specific antigen in the staging of localized prostatecancer:influence of tumor diferentiation,tumor volume and benign hyperplasia.J Urol 1990;143(4):747—752
(责任审校:陈克利)
您现在查看是摘要介绍页，详见PDF附件(1293kb)。